BUSINESS COMBINATIONS (Tables)

3 Months Ended

Apr. 30, 2016

Business Combinations [Abstract]

Schedule of preliminary purchase price allocation

A summary of the purchase price allocation for Reeves-Sain Drug Store, Inc. is as follows (dollars in thousands):

Total purchase consideration:
Cash	$	42,757
Notes payable		13,000
Total purchase consideration	$	55,757
Allocation of the purchase consideration:
Accounts receivables	$	14,474
Inventory		2,005
Other assets		307
Goodwill		41,403
Identifiable intangible assets		20,236
Total assets acquired	$	78,425
Accounts payable	$	21,448
Other current liabilities		1,220
Total liabilities assumed	$	22,668
Net assets acquired	$	55,757

Schedule of identifiable intangible assets acquired

The following are the identifiable intangible assets acquired and their respective weighted average useful lives, as determined based on valuations (dollars in thousands):

	Amount		Estimated Useful Lives (years)
Customer prescription files	$	9,476		4 - 7
Trade name		7,300		-
Non-compete agreements		1,800		8
Referral and relationships		1,400		2
Business licenses		260		1
	$	20,236

Schedule of unaudited pro forma financial information

The unaudited pro forma financial information does not include any adjustments to reflect the impact of cost savings or other synergies that may result from this acquisition.

	Thirteen Weeks Ended
	April 30,		May 2,
(in thousands, except per share data)	2016		2015
Revenue	$	549,548	$	556,398
Earnings		1,256		(725	)
Basic and diluted earnings per share	$	0.03	$	(0.02	)